Chinese patent medicine for treating Parkinson disease and preparation method thereof

Abstract

The invention discloses a Chinese patent medicine for treating Parkinson disease. The Chinese patent medicine is prepared from the following medicinal raw materials in parts by weight: 8-20 parts of malaytea scurfpea fruits, 10-18 parts of fistular onion seeds, 6-15 parts of rhizoma dioscoreae collettii, 10-18 parts of soft-shelled turtle shell glue, 8-16 parts of fortune drynaria rhizomes, 6-15 parts of Chinese taxillus twigs, 6-17 parts of pipe fish, 5-15 parts of mantis egg cases, 5-12 parts of virgate wormwood seedlings, 6-15 parts of sea-ear shells, 5-13 parts of wrinkledfruit amaranth herb, 4-12 parts of gynostemma pentaphyllum, 4-10 parts of Chinese trumpetcreeper stems and leaves, 4-12 parts of commonwedgelet fern leaves, 3-11 parts of common perilla stems, 4-13 parts of radix cynanchi auriculati, 3-10 parts of longyansuo, 5-15 parts of twelve stamen melastoma herb, 4-17 parts of common monkshood daughter roots and 2-10 parts of mumeplant flower buds. According to the theory of the traditional Chinese medicine, the Chinese patent medicine disclosed by the invention has the functions of replenishing qi and blood, nourishing the liver and the kidney, strengthening the spleen, dredging collaterals, eliminating phlegm and dispelling wind, can be used for treating Parkinson disease and can achieve a good treatment effect.

Description

technical field [0001] The invention relates to a Chinese patent medicine for treating Parkinson's disease and a preparation method thereof, belonging to the field of traditional Chinese medicine. Background technique [0002] Parkinson's disease (PD), also known as parkinsonism, is one of the most common neurodegenerative diseases. Epidemiology shows that the prevalence rate is 15-328 / 100,000 population, about 1% of people >65 years old; the incidence rate is 10-21 / 100,000 population / year. To date, the etiology of PD remains unclear. Current research tends to relate to a combination of age, genetic susceptibility, and exposure to environmental toxins. 1) Aging: Parkinson's mainly occurs in middle-aged and elderly people, and the onset is rare before the age of 40, suggesting that aging is related to the onset. The study found that since the age of 30, the activity of dopaminergic neurons in the substantia nigra, tyrosine oxidase and dopa decarboxylase, and the level o...

AI Technical Summary

Problems solved by technology

3) Genetic predisposition

Only short-term curative effect, difficult to obtain materials and other shortcomings, it is less used at present

However, the above-mentioned therapy is subject to many restrictions in the actual use process, and the curative effect is not ideal.